Submission Instructions

November 11, 2022

Submission Steps

You will be prompted to complete the following steps when submitting an abstract. If you are unable to finish your abstract submission in one sitting, you must at least complete Step 1: Abstract Title, in order to have your submission saved and be able to return to the abstract submission site and complete any time prior to the deadline. All abstracts must be completed and submitted by the abstract submission deadline, Monday, December 19th at 1:00 PM EST US. If you do not complete the submission prior to the deadline, your abstract will not be reviewed.

Step 1: Abstract Title 

Step 2: Presentation Type 

Step 3: Science Type and Topic 

Step 4: Authors and Disclosures 

Step 5: COI and Permissions 

Step 6: Abstract Body  

Step 7: Abstract Keywords 

Step 8: Submission Questions 

Step 9: Awards 

Step 10: Payment 

Step 11: Review My Work 

 

Step 1: Abstract Title 
Abstract titles should be short and specific, and entered in title case (the first letter of each word is capitalized, except for certain small words, such as articles, conjunctions, and prepositions). 

For assistance with putting your abstract title in title case, visit www.capitalizemytitle.com.

Example: This Is a Properly Formatted Title 

Step 2: Presentation Type 
You may select your abstract to be considered for an Oral Presentation, Rapid Fire Poster Presentation, or a Traditional Poster Presentation. All accepted abstracts will also be published in a supplemental issue of the Open Access Journal of the Endocrine Society (JES). 

Please Note: Authors of accepted abstracts will receive further information and technical guidelines on how to prepare for their oral, rapid fire, or poster presentation. 

  • Oral Presentation 
    The highest-ranked abstracts are selected for Oral Presentations. These sessions will take place in Chicago June 15 - 18. Presenting authors will have dedicated time to give a 10-minute presentation using slides to summarize their abstract followed by a brief 3–5-minute question and answer session. Note: Abstracts not accepted for an Oral Presentation will automatically be considered for Rapid Fire Poster. 
  • Rapid Fire Presentation 
    Rapid Fire Presentations will also take place in Chicago June 15-18. Presenting authors will give a 2- 5-minute presentation, with the presentation on an electronic screen, highlighting the key points, so interested attendees can ask questions about your work in the subsequent communications. Select this option if you do not wish to be considered for an oral presentation and want to provide a quick synopsis of your work. The Rapid-Fire Poster Presentations will be delivered on a plasma screen with a 16:9 aspect ratio. 
  • Traditional Poster Presentation (Printed Poster) 
    Poster Presentations will take place in-person in Chicago on Thursday, June 15, 2023, through Saturday, June 17, 2023. Presenting authors will be able to display a traditional poster on an expansive poster floor. Poster presenters will be assigned one day to display their printed poster at the conference. During dedicated times on that day, poster presenters will have the opportunity to present and discuss their research with other meeting participants. Select this option if you do not wish to be considered for an oral or rapid-fire presentation and want to take advantage of presenting your work in-person and not on an electronic screen. 

Step 3: Science Type and Topic 
Basic, clinical, and translational scientific abstracts, clinical trials are accepted for submission across 132 topical areas, and clinical case reports are accepted for submission in 16 topical areas. View the complete list of 2023 Abstract Topical Areas

  • Basic Scientific Research - Submissions should report basic endocrine research (e.g., physiological or molecular biological research in cell cultures or animal models).  
  • Translational Scientific Research - Submissions should report mechanistic endocrine research in humans, human tissues, tumor cells, or animal models that have a direct relationship to human physiology or disease.  
  • Clinical Scientific Research - Submissions should report endocrine research investigating or concerning specific disease states (e.g., evaluation of diagnostic techniques and therapies).  
  • Clinical Trial - Submissions should report data about the safety or potential benefit of an endocrine intervention such as a medication, device, teaching concept, training method, or behavioral change in human subjects.  
  • Clinical Case Report - Submissions should report valuable/novel teaching points or learning lessons from clinical care of endocrine disorders. In addition to consideration for presentation at ENDO, clinical case reports will be considered for use in other educational formats, online or in print.  

For detailed information on submitting abstracts view:  

Step 4: Authors and Disclosures 
Authors 
Edits to authors will not be accepted after the abstract submission site has closed. Please review this information carefully to ensure you have included all authors. You may also change the presenting author here at any time up until the abstract submission site closes (NOTE: There can be only one Presenting Author in your submission).  

Enter contact information and disclosures for the presenting author. Based on the disclosures entered for the presenting author, complete the Conflict of Interest (COI) resolution and recording permissions. If you change the presenting authors, you must also update the COI and permissions pertinent to the new presenting author. 

Disclosures 
FACULTY DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS & RESOLUTION OF CONFLICTS OF INTEREST 
In accordance with requirements of the Accreditation Council for Continuing Medical Education (ACCME), the Endocrine Society requires all individuals who are in a position to control the content of a CME activity to disclose all financial relationships with any commercial interest that produces, markets, resells, or distributes healthcare goods or services consumed by or used on patients. 

Financial relationships are defined as remuneration paid to you in any amount that has occurred within the last 24 months when these two conditions apply: 

  • You have financial relationship with a commercial interest 
  • You have the opportunity to affect CME content related to the products or services of that commercial interest 

If a potential conflict of interest exists as a result of a financial relationship, this will need to be resolved prior to the activity. All financial relationships must be disclosed to learners at the beginning of the CME activity. If no financial relationships exist, learners must be informed of that as well. 

Step 5: COI and Permissions 
Conflict of Interest 
If you listed a conflict of interest for your abstract presentation when you completed your disclosures and a potential conflict exists as a result of a financial relationship, this will need to be resolved prior to the activity. Please complete this step to assist with resolving any potential conflict of interests so that the Endocrine Society may provide CME on your presentation. 

Session Recording Permissions 
The Endocrine Society will record your presentation, with your consent and will make the recording available through Endocrine Society distribution channels. In this section, please select your options and provide requested information here. 

Step 6: Abstract Body 

  • Character Limit: Maximum of 2,500 characters, including punctuation (not spaces), for the text of your abstract body. Figures, tables, graphs will not be accepted. References are allowed but not required and should be included in the body of your abstract. If you include references, they will count toward the 2,500-character limit. 
  • Abstract Body: Select "Enter Abstract Text" below to type in your abstract or copy and paste it from an existing document, or "Upload a File Containing Your Abstract". To preserve formatting and scientific characters in your abstract text, uploading a file containing your abstract is the preferred option. You may upload any .doc or .docx file, but the total character limit must not exceed 2,500. PLEASE NOTE: To preserve the blind peer review process, do not include any identifying information (institution or author names) in your abstract. All co-authors/primary investigators, their institutional affiliations, and any disclosures must be entered in Step 4: AUTHORS AND DISCLOSURES.
  • Graphics (e.g., figures and tables) are not accepted in the body of your abstract. 

IMPORTANT: Please carefully review your abstract and author information before finalizing your submission. Presenting authors may edit their abstract by returning to the abstract submission site at any time prior to the submission deadline. No edits can be made once the submission site closes on Monday, December 19, 2022, at 1:00 PM EST US. Accepted abstracts will be published online in the ENDO program, in the ENDO mobile app (if applicable), and in the Journal of the Endocrine Society (JES). Authors will not have an opportunity to review or approve proofs of their abstract before it appears online and in JES, and corrections after publication in JES are not possible. 

Step 7: Abstract Keywords 
Keywords help others search for and find your abstract when using the ENDO 2022 Meeting Platform. Select keywords from a drop-down menu that would likely be used to search for your abstract. Minimum of 1 keyword and maximum of 3 keywords. 

Please carefully review your abstract and author information before clicking the "Save and Continue" button. Make any edits if necessary. 

Step 8: Submission Questions 

  • Question 1: Principal Investigator – provide the PI of your research 
  • Question 2: Religious Conflicts – indicate if any conflicts exist which would prevent you from presenting on certain days 
    • I do not have any religious scheduling conflicts. 
    • I cannot present on Thursday, June 15, 2023, because of a religious observation. 
    • I cannot present on Friday, June 16, 2023, because of a religious observation. 
    • I cannot present on Saturday, June 17, 2023, because of a religious observation. 
  • Question 3: Embargo and Publication Restriction – indicate if you do not want your full abstract posted online until the date of your presentation. 
  • Question 4: Special Poster Recognition – During ENDO 2023, some top-scoring abstracts submitted for poster presentation will be recognized for their excellence and receive additional exposure for their work. All eligible authors are invited to participate and winners will be notified upon selection. 
    Eligibility criteria: 
    • You MUST be the first and presenting author on the abstract submission 
    • You MUST be currently in-training (Graduate Student, Medical School Student, Resident/Intern, Postdoctoral Fellow, or Clinical Fellow) 
  • Question 5: Quality Improvement and Patient Safety – Indicate if abstract covers quality improvement and patient safety. 

Step 9: Awards (Optional)  
The Endocrine Society provides awards to recognize outstanding work in endocrinology. These recognition awards are given to outstanding abstracts submitted by in-training fellows and new faculty whom who have been accepted to present their research during the online annual meeting (ENDO). Please visit endocrine.org/awards for award criteria and more information. 

Standard Award Requirements: 

  • You MUST be the first and presenting author on the abstract submission 
  • You MUST be currently in-training (Graduate Student, Medical School Student, Clinical or Post-Doctoral Fellow) or early career junior faculty (within 3 years of completing your fellowship and/or 1st - 2nd year of appointment) 
  • You MUST be an Endocrine Society member to be considered for an abstract-based award. Learn more about the benefits of membership, including discounted ENDO registration, at endocrine.org/join

Please note: In-person attendance at ENDO 2023 is required to receive the award. The travel award program is not offered virtually. Members are eligible to receive one travel award or travel reimbursement per meeting. If you are selected for more than one travel award you will receive the higher monetary value. 

Step 10: Payment 
The ENDO 2023 abstract handling fee is $90 (USD) per abstract. Abstract fees are non-refundable.. The Endocrine Society accepts Visa, Master Card, and American Express. If you need to make a wire transfer payment, please email [email protected] to request instructions.  Note: Paying the abstract handling fee does not register you for ENDO 2023. All abstract presenters must register to attend ENDO 2023. 

If you are having difficulty finalizing your payment, please contact [email protected] or call +1 (217) 398-1792. 

Step 11: Review My Work 
Please carefully review your abstract and author information before the abstract submission site closes. No edits can be made once the submission site closes on Monday, December 19, 2022, at 1:00 PM EST US. Accepted abstracts will be published online in the ENDO program, in the ENDO mobile app (if applicable), and in the Journal of the Endocrine Society (JES). Authors will not have an opportunity to review or approve proofs of their abstract before it appears online and in JES, and corrections after publication in JES are not possible.  

You will receive an email confirming your submission. Return to the submission site at any time before the submission deadline to make edits to your abstract. All abstracts must be completed and submitted by the abstract submission deadline, Monday, December 19th at 1:00 PM EST US. If you do not complete the submission prior to the deadline, your abstract will not be reviewed. 

Please make all changes before the abstract submission site closes. No edits can be made to your abstract after the submission site closes on Monday, December 19, 2022, at 1:00 PM EST US. 

AFTER YOUR ABSTRACT HAS BEEN SUBMITTED 

Edits 
Submitting (contact) authors may use the link provided through their submission confirmation email to edit their abstract up until the abstract submission deadline. NO REVISIONS to the abstract or the list of authors will be allowed once the site closes on the deadline date.  

Abstract Withdrawal 
Abstracts may be withdrawn by sending an email to [email protected]. Withdrawal requests must be submitted by the submitting (contact) author and include the abstract submission confirmation number. The $90 abstract handling fee is not refundable. 

Notice of Abstract Acceptance  
Abstract notifications will be emailed to presenting authors and co-authors in mid-February. 

Abstract Sessioning 
Authors of accepted abstracts will receive presentation details, information and technical guidelines on how to prepare for their oral or poster presentation in late-February. Presenting authors will not be allowed to reschedule their presentation except for religious reasons (as identified in Step 8 of the submission process). 

Abstract Publication 
All accepted abstracts from registered presenters will be published on the meeting website and in a supplemental issue of the Open Access Journal of the Endocrine Society (JES), assigned a DOI, and indexed in PubMed and PubMed Central. 

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.